A carregar...
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Given the multi-faceted pathogenesis of atherosclerosis in type 2 diabetes mellitus (T2DM), it is likely that interventions to mitigate this risk must address cardiovascular (CV) risk factors beyond glucose itself. Sodium glucose cotransporter-2 (SGLT-2) inhibitors are newer antihyperglycaemic agent...
Na minha lista:
| Publicado no: | Diab Vasc Dis Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361459/ https://ncbi.nlm.nih.gov/pubmed/25589482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164114559852 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|